This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Mar 1;27(7):1148-9; author reply 1149-50.

doi: 10.1200/JCO.2009.21.2274. Epub 2009 Jan 26.

Combining docetaxel with estramustine: back to the future?

Stéphane Oudard, Jean Christophe Eymard, Karim Fizazi

PMID: 19171697
DOI: 10.1200/JCO.2009.21.2274

Comment

Combining docetaxel with estramustine: back to the future?

Stéphane Oudard et al. J Clin Oncol. 2009.

. 2009 Mar 1;27(7):1148-9; author reply 1149-50.

doi: 10.1200/JCO.2009.21.2274. Epub 2009 Jan 26.

Authors

Stéphane Oudard, Jean Christophe Eymard, Karim Fizazi

PMID: 19171697
DOI: 10.1200/JCO.2009.21.2274

No abstract available

PubMed Disclaimer

Comment on

Prospective randomized study comparing docetaxel, estramustine, and prednisone with docetaxel and prednisone in metastatic hormone-refractory prostate cancer.
Machiels JP, Mazzeo F, Clausse M, Filleul B, Marcelis L, Honhon B, D'Hondt L, Dopchie C, Verschaeve V, Duck L, Verhoeven D, Jousten P, Bonny MA, Moxhon AM, Tombal B, Kerger J. Machiels JP, et al. J Clin Oncol. 2008 Nov 10;26(32):5261-8. doi: 10.1200/JCO.2008.16.9524. Epub 2008 Sep 15. J Clin Oncol. 2008. PMID: 18794543 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information